Researchers working with a revolutionary genes editing tool have identified thousands of genes that are important for the survival of cancer cells, exposing the prospect of significant success in the treatment. The Crispr / Cas9 system violates each gene within 30 different cancers.
One identified gene is the Werner's Recq helicase syndrome, which the researchers found necessary to preserve living some of the most volatile types of cancer, but which can not currently be targeted.
The study, which was a collaboration between the Wellcome Sanger Institute, the European Institute of Bioinformatics and the pharmaceutical company GlaxoSmithKline, was published in the journal Nature on Wednesda y.
This can help reduce the cost of effective cancer treatment: the institute said it currently costs more than $ 1 billion (£ 760m) to make one drug, and that 90% of them are not in testing and
Praiseworthy The tool that made the breakthrough possible, Dr. Kosuke Yus, co-chairman of the authors of the findings, said that Crisper was "incredibly powerful" and "allows us to do science on a scale and with the precision that we
" With Crispr we found it very interesting an opportunity to develop new cancer-focused drugs. "
Dr. Matthew Garnett, also co-chairman, said:" The map from dependence cancer is a huge effort to identify all the weaknesses that exist in different types of cancer, so we can use this information to empower the next generation of cancer treatments more accurate cancer.
Effective Therapy "[1965900ProfKarenNewswomanScientificDepartmentofLaborVersionBritishBBCNews:"It'sastudyofsopowerfulasascale
"This work provides excellent starting points, and the next step is a thorough analysis of genes that have been identified as weaknesses in this study to determine if they will be one The day will lead to the development of new treatments for patients. "